Skip to main content
Binex Co., Ltd. logo

Binex Co., Ltd. — Investor Relations & Filings

Ticker · 053030 ISIN · KR7053030003 KO Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2024-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 053030

About Binex Co., Ltd.

http://www.binex.co.kr/

Binex Co., Ltd. is a biopharmaceutical company engaged in two main sectors: synthetic pharmaceuticals and biologics contract services. The pharmaceutical division manufactures and distributes a portfolio of products, including gastrointestinal tract regulators, antispasmodics, and anti-cancer drugs. As a Contract Development and Manufacturing Organization (CDMO), the company provides comprehensive services for biologics, specializing in cell line development, process development, and analytical method development. Its quality management systems are recognized by major international regulatory authorities such as the FDA, EMA, and PMDA, establishing it as a key partner in biopharmaceutical development and manufacturing.

Recent filings

Filing Released Lang Actions
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Binex' covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial and operational information, including company overview, history, capital structure, and management details, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding collateral loan contract extensions for major shareholders. This falls under the category of Major Shareholding Notification (MRQ).
2024-04-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (AGM). It details the approval of financial statements, the election of directors and auditors, and the results of voting on various agenda items. This aligns perfectly with the definition of a Declaration of Voting Results (DVA).
2024-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of the audit opinion (unqualified/appropriate), key financial data (assets, liabilities, revenue, profit/loss), and auditor information. While it contains financial data, it is a standardized regulatory disclosure form announcing the receipt and submission of the audit report rather than the full, multi-page audited financial statement document itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2023
2024-03-15 Korean
사업보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Binex Co., Ltd. (주식회사 바이넥스) for the fiscal year ending December 31, 2023. It includes the independent auditor's opinion, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. While it contains financial data, it is specifically the auditor's report and the accompanying financial statements, which falls under the 'Audit Report / Information' category rather than a full 10-K annual report or a simple earnings release. FY 2023
2024-03-15 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Binex) announcing a significant change in financial results (revenue or profit structure change of 30% or more). This is a standard regulatory disclosure requirement in the Korean market (DART system) for listed companies to report material financial fluctuations before the final audit report is finalized. It provides key financial highlights and reasons for the variance, fitting the definition of an Earnings Release (ER) as it serves as an initial announcement of financial performance metrics. FY 2023
2024-03-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.